Context Therapeutics Reports Third Quarter 2023 Operating and Financial Results

Go back to Context Therapeutics Reports Third Quarter 2023 Operating and Financial Results
(NASDAQ: CNTX) Delayed: 0.52 +0.01 (1.96%)
Previous Close $0.51    52 Week High
Open $0.50    52 Week Low
Day High $0.54    P/E N/A 
Day Low $0.49    EPS
Volume 1,263,849